Robert Driscoll

Stock Analyst at Wedbush

(0)
# 4775
Out of 5,298 analysts
201
Total ratings
19.42%
Success rate
-26.50%
Average return
Main Sectors:
Top Industries:
39 Stocks
Name Action Price Target Current % Upside Ratings Updated
ZNTL Zentalis Pharma
Reiterates: Neutral
4 4
1.27 214.96% 10 Mar 28, 2025
GLUE Monte Rosa Therapeut...
Maintains: Outperform
15 17
3.81 346.19% 4 Mar 21, 2025
HOWL Werewolf Therapeutic...
Reiterates: Outperform
8 8
0.75 966.67% 2 Mar 12, 2025
ARVN Arvinas
Downgrades: Neutral
57 12
6.63 81% 9 Mar 12, 2025
DAWN Day One Biopharmaceu...
Reiterates: Outperform
32 32
7.42 331.27% 6 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 36
6.07 493.08% 8 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
52 52
15.32 239.43% 9 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
70 67
32.18 108.2% 4 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
28 28
8.09 246.11% 8 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
16 16
1.45 1003.45% 10 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 30
7.29 311.52% 7 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 22
1.14 1829.82% 10 Oct 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 51
4.93 934.48% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5 5
0.68 635.29% 8 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
36 36
7.52 378.72% 4 Sep 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
1.72 539.53% 3 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13 13
3.75 246.67% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 13
1.28 915.62% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
25.2 193.65% 7 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
n/a n/a 4 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
1.61 396.89% 3 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
7 7
1.4 400% 8 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
65
n/a n/a 8 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
3 8
0.48 1566.67% 9 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
0.24 3233.33% 7 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
52
7.5 593.33% 5 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 1
n/a n/a 4 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
3
n/a n/a 3 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 36
n/a n/a 2 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
50 70
n/a n/a 4 May 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
9 2
n/a n/a 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
136 17
n/a n/a 3 Mar 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
5 9
n/a n/a 6 Jun 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
2 4
3.35 19.4% 4 May 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1500 250
n/a n/a 1 Mar 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 3
n/a n/a 3 Nov 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 34
n/a n/a 1 Apr 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
120 160
n/a n/a 1 Feb 22, 2017